Cadila Healthcare has informed that it has enclosed a copy of press release dated March 24, 2021 titled ‘Remdac™ (Remdesivir) from Zydus now more affordable at Rs 899’. The contents of the press release give full details. Bring the aforesaid news to the notice of the members of the exchange and the investors’ at large.
The above information is a part of company’s filings submitted to BSE.